Orca Bio is transforming the transplant process by developing next-generation cell therapies that offer improved survival rates and fewer risks. Their advanced, high-precision investigational therapies aim to replace patients' blood and immune systems with healthy alternatives, offering the potential to restore lives and improve patient outcomes.